Intestinal barrier function and serum concentrations of rifampin, isoniazid and pyrazinamide in patients with pulmonary tuberculosis

Intestinal barrier function and serum concentrations of rifampin, isoniazid and pyrazinamide in patients with pulmonary tuberculosis

Intestinal barrier function and serum concentrations of rifampin, isoniazid and pyrazinamide were studied in healthy controls and patients with active pulmonary tuberculosis. A case-control study of 29 controls and 30 cases attending at the Health Center, July, 2004 to December, 2005 was conducted....

Full description

Bibliographic Details
Main Authors:	Mônica C. Façanha, Argina M.B. Gondim, Valéria G.F. Pinheiro, Elizabeth C. Barroso, Charles A. Peloquin, Richard L. Guerrant, Aldo A.M. Lima
Format:	Article
Language:	English
Published:	Elsevier
Series:	Brazilian Journal of Infectious Diseases
Subjects:	Tuberculosis bioavailability of antimycobacterial drugs intestinal barrier function rifampin isoniazid and pyrazinamide
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702009000300011&lng=en&tlng=en

Similar Items

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in <it>Mycobacterium tuberculosis</it>
by: Parsons Linda M, et al.
Published: (2001-04-01)

Assessment of adherence to antituberculosis drug regimen among patients receiving isoniazid, rifampin and pyrazinamide: Kerman, Iran
by: Seyyed Mojtaba Sohrevardi, et al.
Published: (2019-07-01)

Intestinal permeability and malabsorption of rifampin and isoniazid in active pulmonary tuberculosis
by: Valéria G. F. Pinheiro, et al.

Evaluation of disease patterns, treatment and prognosis of tuberculosis in AIDS patient
by: Angela Naomi Atomiya, et al.

Evaluation of disease patterns, treatment and prognosis of tuberculosis in AIDS patient
by: Atomiya Angela Naomi, et al.
Published: (2002-01-01)

Drug Resistance in Mycobacterium Tuberculosis Isolates to Isoniazid and Rifampin
by: M Pourhajibagher, et al.
Published: (2012-05-01)

SIMULTANEOUS CONTENT ANALYSIS OF RIFAMPICIN, ISONIAZID, AND PYRAZINAMIDE IN TABLET DOSAGE FORM BY SPECTROPHOTOMETRY ULTRAVIOLET WITH DWM AND RSM
by: Muhammad Andry, et al.
Published: (2022-11-01)

CNS tuberculoma in an immunocompetent patient: A case report of multi-drug hypersensitivity to RIPE therapy
by: Benjamin Huber, et al.
Published: (2023-01-01)

Is the Pharmacokinetics of First-Line Anti-TB Drugs a Cause of High Mortality Rates in TB Patients Admitted to the ICU? A Non-Compartmental Pharmacokinetic Analysis
by: Francisco Beraldi-Magalhaes, et al.
Published: (2023-06-01)

Hepatoprotective activity of the ethanol extract of Curcuma heyneana rhizome on isoniazid and rifampin-induced liver injury rats
by: Marianne Marianne, et al.
Published: (2020-10-01)

New combination for patients with latent tuberculosis infection: A pilot study
by: Te-Yu Lin, et al.
Published: (2018-01-01)

A Simple and Sensitive UPLC–UV Method for Simultaneous Determination of Isoniazid, Pyrazinamide, and Rifampicin in Human Plasma and Its Application in Therapeutic Drug Monitoring
by: Zhimei Jiang, et al.
Published: (2022-04-01)

An Evaluation of the In Vitro Roles and Mechanisms of Silibinin in Reducing Pyrazinamide- and Isoniazid-Induced Hepatocellular Damage
by: Zhang-He Goh, et al.
Published: (2020-05-01)

Synthesis and antitubercular activity of isoniazid condensed with carbohydrate derivatives
by: Sílvia H. Cardoso, et al.
Published: (2009-01-01)

Evaluation of the frequency of resistance to 2 drugs (Isoniazid and Rifampin) by molecular investigation and it's risk factors in new cases of smear positive pulmonary tuberculosis in health centers under the cover of Jundishapur University of Medical Sciences in 2017
by: Shokrollah Salmanzadeh, et al.
Published: (2020-01-01)

Development of a HPLC Method for Analysis of a Combination of Clofazimine, Isoniazid, Pyrazinamide, and Rifampicin Incorporated into a Dermal Self-Double-Emulsifying Drug Delivery System
by: Daniélle van Staden, et al.
Published: (2023-11-01)

In vitro synergic effect of ²-lapachone and isoniazid on the growth of Mycobacterium fortuitum and Mycobacterium smegmatis
by: Joas L da Silva, et al.
Published: (2009-07-01)

Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis
by: Sirous M, et al.
Published: (2018-10-01)

Effect of Carum carvi, a herbal bioenhancer on pharmacokinetics of antitubercular drugs: A study in healthy human volunteers
by: Naiyma Choudhary, et al.
Published: (2014-01-01)

Evidenziazione molecolare di resistenza di Mycobacterium tuberculosis complex a rifampicina e isoniazide
by: Gian Lorenzo Molinari, et al.
Published: (2006-06-01)

Molecular drug susceptibility testing against the first-line (rifampin and isoniazid) and second-line (ciprofloxacin–amikacin and kanamycin) treatment in different subtypes of Mycobacterium simiae
by: Parissa Farnia, et al.
Published: (2016-01-01)

Investigation of Rifampin Serum Levels in Patients Diagnosed with Tuberculosis Treated with the Drug Regimen Mazandaran, 2020-2021
by: Lotfollah Davoodi, et al.
Published: (2023-11-01)

Mutations in rpoB and katG genes in Mycobacterium isolates from the Southeast of Mexico
by: R Zenteno-Cuevas, et al.
Published: (2009-05-01)

A comparative study on the adverse effects of two anti-tuberculosis drugs regimen in initial two-month treatment period
by: Begum Lutfun Nahar, A.K.M. Mosharrof Hossain, M. Monirul Islam and Dipti Rani Saha
Published: (2006-12-01)

Stability Study of Isoniazid and Rifampicin Oral Solutions Using Hydroxypropyl-Β-Cyclodextrin to Treat Tuberculosis in Paediatrics
by: Ana Santoveña-Estévez, et al.
Published: (2020-02-01)

<i>N</i>-Pyrazinoyl Substituted Amino Acids as Potential Antimycobacterial Agents—the Synthesis and Biological Evaluation of Enantiomers
by: Martin Juhás, et al.
Published: (2020-03-01)

5-Alkylamino-<i>N</i>-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation
by: Weronika Ambrożkiewicz, et al.
Published: (2020-03-01)

Synthesis, Antimycobacterial Activity and In Vitro Cytotoxicity of 5-Chloro-N-phenylpyrazine-2-carboxamides
by: Jan Zitko, et al.
Published: (2013-12-01)

Retrospective Analysis of Archived Pyrazinamide Resistant <i>Mycobacterium tuberculosis</i> Complex Isolates from Uganda—Evidence of Interspecies Transmission
by: Sylvia I. Wanzala, et al.
Published: (2019-07-01)

Mutations in Efflux Pump Rv1258c (Tap) Cause Resistance to Pyrazinamide, Isoniazid, and Streptomycin in M. tuberculosis
by: Jiayun Liu, et al.
Published: (2019-02-01)

Pharmacokinetics of antitubercular drugs in patients hospitalized with HIV-associated tuberculosis: a population modeling analysis [version 3; peer review: 1 approved, 2 approved with reservations]
by: Helen McIlleron, et al.
Published: (2024-03-01)

Pharmacokinetics of antitubercular drugs in patients hospitalized with HIV-associated tuberculosis: a population modeling analysis [version 2; peer review: 1 approved, 2 approved with reservations]
by: Helen McIlleron, et al.
Published: (2022-11-01)

The Prospective Synergy of Antitubercular Drugs With NAD Biosynthesis Inhibitors
by: Kyle H. Rohde, et al.
Published: (2021-01-01)

Hepatoprotective effects of Malus hupehensis tea against isoniazid- and rifampicin-induced liver injury by regulating cytochrome P450 in mice
by: Guorong Li, et al.
Published: (2021-09-01)

Deranged Haemostasis: Rifampin-Induced Coagulopathy
by: Raghu Tiperneni, et al.
Published: (2022-05-01)

New insights into the mechanism of action of pyrazinamide, implications for susceptibility testing, and future regimens*
by: Richard M Anthony, et al.
Published: (2016-01-01)

In vitro Evaluation of Isoniazid Derivatives as Potential Agents Against Drug-Resistant Tuberculosis
by: Joaquim Trigo Marquês, et al.
Published: (2022-05-01)

Tuberculose resistente: revisão molecular
by: Maria Lúcia Rosa Rossetti, et al.

Ability of the MeltPro MTB/PZA Assay to Detect Susceptibility to Pyrazinamide in Rifampin-Resistant Tuberculosis Patients
by: Rong Li, et al.
Published: (2023-06-01)

Pyrazinamide-induced phototoxicity: A case report and review of literature
by: Katiyar Subodh, et al.
Published: (2010-01-01)